Clinical trial
Efficacy and Safety of Intracalvariosseous Combined With Intravenous Injection of Antibiotics in Moderate-to-Severe Bacterial Meningitis
NCT07495150 is registered in ClinicalTrials.gov with yilong Wang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Intracalvariosseous Combined With Intravenous Injection of Antibiotics in Moderate-to-Severe Bacterial Meningitis
- Lead sponsor
- yilong Wang
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- July 1, 2027
- Enrollment
- 86 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial meningitis, blood-brain barrier